Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Booz Allen Hamilton
BAH
$9.27B
| $1.4M | 0.09% |
20,394
+5,052
| +33% | +$372K |
|
277
Alcon
ALC
$35.6B
| $1.38M | 0.09% |
27,213
+22,213
| +444% | +$1.28M |
|
|
DISH
278
DELISTED
DISH Network Corp.
DISH
| $1.38M | 0.09% |
69,102
+58,702
| +564% | +$1.9M |
|
279
DexCom
DXCM
$34.8B
| $1.37M | 0.09% |
20,400
-2,864
| -12% | -$178K |
|
|
ALXN
280
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.37M | 0.09% |
15,272
+5,265
| +53% | +$517K |
|
|
FIT
281
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.36M | 0.09% |
+205,000
| New | +$1.33M |
|
|
LSXMK
282
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.36M | 0.09% |
56,588
-177,379
| -76% | -$5.94M |
|
|
OSB
283
DELISTED
Norbord Inc.
OSB
| $1.36M | 0.09% |
115,002
+49,202
| +75% | +$1.24M |
|
284
Maximus
MMS
$3.05B
| $1.35M | 0.09% |
23,180
+19,033
| +459% | +$1.29M |
|
285
Hanover Insurance
THG
$7.77B
| $1.34M | 0.08% |
14,800
+10,800
| +270% | +$1.34M |
|
286
Sensata Technologies
ST
$6.23B
| $1.34M | 0.08% |
+46,255
| New | +$2M |
|
287
Brown-Forman Class B
BF.B
$13.1B
| $1.33M | 0.08% |
+24,056
| New | +$1.55M |
|
288
Southern Company
SO
$102B
| $1.33M | 0.08% |
+24,581
| New | +$1.56M |
|
289
Cincinnati Financial
CINF
$25.8B
| $1.32M | 0.08% |
17,505
-2,892
| -14% | -$288K |
|
290
J.M. Smucker
SJM
$13.3B
| $1.31M | 0.08% |
11,800
-5,047
| -30% | -$540K |
|
291
Gartner
IT
$12.4B
| $1.3M | 0.08% |
13,106
+7,358
| +128% | +$1.01M |
|
|
AYX
292
DELISTED
Alteryx Inc
AYX
| $1.3M | 0.08% |
13,618
-157,882
| -92% | -$19.6M |
|
|
BMY.RT
293
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.29M | 0.08% |
340,300
+201,000
| +144% | +$662K |
|
294
Franco-Nevada
FNV
$51.3B
| $1.28M | 0.08% |
+12,900
| New | +$1.4M |
|
295
Dycom Industries
DY
$11.8B
| $1.28M | 0.08% |
50,000
-184,600
| -79% | -$6.53M |
|
|
MRTX
296
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.28M | 0.08% |
16,655
-11,482
| -41% | -$1.03M |
|
297
Agilent Technologies
A
$44.9B
| $1.27M | 0.08% |
+17,731
| New | +$1.42M |
|
298
W.W. Grainger
GWW
$61.8B
| $1.27M | 0.08% |
5,106
-59,822
| -92% | -$17.7M |
|
299
Cousins Properties
CUZ
$4.89B
| $1.27M | 0.08% |
+43,300
| New | +$1.6M |
|
300
Paylocity
PCTY
$8.14B
| $1.26M | 0.08% |
+14,312
| New | +$1.8M |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.